Revolutionizing Pediatric Cancer Diagnosis and Treatment Through Molecular Profiling

Watch a compelling 23-minute webinar featuring Dr. Alanna Church, a Molecular and Pediatric Pathologist at Boston Children's Hospital, as she explores the transformative potential of molecular profiling in pediatric cancer care. Discover how molecular tumor profiling is emerging as a crucial tool for improving diagnosis and treatment outcomes for children with cancer, with findings showing clinically relevant molecular alterations in 86% of pediatric solid tumor cases. Learn about the evolution of pediatric cancer treatment, from traditional clinical trials to personalized medicine approaches, and understand the importance of precise diagnosis and targeted therapies. Gain insights into ongoing national initiatives and institutional projects aimed at enhancing molecular testing accessibility for pediatric cancer patients, including the Profile study and GAIN consortium study. Explore the future of pediatric oncology where molecular profiling ensures each child receives appropriate testing, accurate diagnosis, and optimal treatment strategies.